RxDoctor Payments Data

Valerie Miller, PA

Physician Assistant · Portland, ORNPI 1548711997

Payments from drug & device makers

$814in general payments, 2019–2025

Across 25 payments — averaging $32.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$255
  • AbbVie$147
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$118
  • AstraZeneca$77
  • Sumitomo Pharma America, Inc.$54
  • Lilly USA, LLC$52
  • plus $110 from 4 others

What the payments were for

  • Food & beverage$814100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$814 in reported general payments places this provider in the 80th percentile of 1,756 physician assistant providers in Oregon.

See all physician assistant providers in Oregon

Medicare billing

Part B allowed, 2024
$1,645
Medicare patients
14
Services billed
34

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide11$12,363
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen28$886
Duloxetine Hcl14$550
Omeprazole18$351
Metoprolol Succinate26$232
Fluoxetine Hcl13$229
Levothyroxine Sodium27$222
Losartan Potassium22$201
Atorvastatin Calcium23$193
Lisinopril34$175
Gabapentin12$157
Rosuvastatin Calcium13$142
Furosemide21$130
Simvastatin17$114
Amlodipine Besylate25$109

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$52$12,36311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,756 physician assistant providers in Oregon.

Other physician assistant in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →